


Programs
Aiming to treat β-thalassemia and sickle cell disease with gene-edited hematopoietic stem cells




Press Releases
Apr 10, 2021
Apr 06, 2021
CRISPR Therapeutics to Participate in the 20th Annual Needham Virtual Healthcare Conference
Mar 10, 2021



Join Our Team
We're looking for energetic, collaborative and talented people who like challenges, want to make a difference and have a track record of delivering results. View open opportunities


You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.